The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population
- PMID: 24022983
- PMCID: PMC4085151
- DOI: 10.1002/mpr.1397
The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population
Abstract
Attention deficit/hyperactivity disorder (ADHD) is an increasingly recognized comorbid condition in subjects with substance use disorders (SUDs). This paper describes the methods and study population of the International ADHD in Substance Use Disorders Prevalence (IASP) study. Objectives of the IASP are to determine the prevalence of ADHD in adult treatment seeking patients with SUD in different countries and SUD populations, determine the reliability and validity of the Adult ADHD Self-report Scale V 1.1 (ASRS) as ADHD screening instrument in SUD populations, investigate the comorbidity profile of SUD patients with and without ADHD, compare risk factors and protective factors in SUD patients with and without a comorbid diagnosis of ADHD, and increase our knowledge about the relationship between ADHD and the onset and course of SUD. In this cross-sectional, multi-centre two stage study, subjects were screened for ADHD with the ASRS, diagnosed with the Conner's Adult ADHD Diagnostic Interview for DSM-IV (CAADID), and evaluated for SUD, major depression, bipolar disorder, anti social personality disorder and borderline personality disorder. Three thousand five hundred and fifty-eight subjects from 10 countries were included. Of these 40.9% screened positive for ADHD. This is the largest international study on this population evaluating ADHD and comorbid disorders.
Keywords: ADHD; attention/deficit hyperactivity disorder; prevalence; substance use disorders.
Copyright © 2013 John Wiley & Sons, Ltd.
Conflict of interest statement
The other authors did not report any conflict of interest.
Figures
Similar articles
-
The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities.Eur Addict Res. 2020;26(4-5):173-178. doi: 10.1159/000508870. Epub 2020 Jun 29. Eur Addict Res. 2020. PMID: 32599579 Free PMC article. Review.
-
Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.Addiction. 2014 Feb;109(2):262-72. doi: 10.1111/add.12370. Epub 2013 Nov 20. Addiction. 2014. PMID: 24118292 Free PMC article.
-
Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients.Drug Alcohol Depend. 2013 Oct 1;132(3):587-96. doi: 10.1016/j.drugalcdep.2013.04.010. Epub 2013 May 6. Drug Alcohol Depend. 2013. PMID: 23660242 Free PMC article.
-
Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.Eur Addict Res. 2020;26(4-5):201-210. doi: 10.1159/000508546. Epub 2020 Jun 22. Eur Addict Res. 2020. PMID: 32570249
-
The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.Curr Opin Psychiatry. 2012 May;25(3):219-25. doi: 10.1097/YCO.0b013e3283523d7c. Curr Opin Psychiatry. 2012. PMID: 22449768 Review.
Cited by
-
Childhood trauma exposure in substance use disorder patients with and without ADHD.Addict Behav. 2017 Feb;65:118-124. doi: 10.1016/j.addbeh.2016.10.016. Epub 2016 Oct 24. Addict Behav. 2017. PMID: 27816036 Free PMC article.
-
Cognitive Remediation as an Adjunct Treatment for Substance Use Disorders: A Systematic Review.Neuropsychol Rev. 2022 Mar;32(1):161-191. doi: 10.1007/s11065-021-09506-3. Epub 2021 Apr 19. Neuropsychol Rev. 2022. PMID: 33871785
-
Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study.Eur Addict Res. 2015;21(4):188-94. doi: 10.1159/000371724. Epub 2015 Apr 1. Eur Addict Res. 2015. PMID: 25832736 Free PMC article.
-
The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities.Eur Addict Res. 2020;26(4-5):173-178. doi: 10.1159/000508870. Epub 2020 Jun 29. Eur Addict Res. 2020. PMID: 32599579 Free PMC article. Review.
-
Substance Use, Health, and Adverse Life Events amongst Amphetamine-Type Stimulant Users in North East England: A Cross-Sectional Study.Int J Environ Res Public Health. 2022 Jun 7;19(12):6996. doi: 10.3390/ijerph19126996. Int J Environ Res Public Health. 2022. PMID: 35742245 Free PMC article.
References
-
- Arcos‐Burgos M., Jain M., Acosta M.T., Shively S., Stanescu H., Wallis D., Domené S., Vélez J.I., Karkera J.D., Balog J., Berg K., Kleta R., Gahl W.A., Roessler E., Long R., Lie J., Pineda D., Londoño A.C., Palacio J.D., Arbelaez A., Lopera F., Elia J., Hakonarson H., Johansson S., Knappskog P.M., Haavik J., Ribases M., Cormand B., Bayes M., Casas M., Ramos‐Quiroga J.A., Hervas A., Maher B.S., Faraone SV., Seitz C., Freitag C. M., Palmason H., Meyer J., Romanos M., Walitza S., Hemminger U., Warnke A., Romanos J., Renner T., Jacob C., Lesch K.P., Swanson J., Vortmeyer A., Bailey‐Wilson J.E., Castellanos F.X., Muenke M.. (2010) A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Molecular Psychiatry, 15, 1053–1066, DOI: 10.1038/mp.2010.6. - DOI - PubMed
-
- Adler L.A., Guida F., Irons S., Rotrosen J., O'Donnell K. (2009) Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility. Postgraduate Medicine, 121(5), 7–10. - PubMed
-
- Batstra L., Frances A. (2012) Holding the line against diagnostic inflation in psychiatry. Psychotherapy and Psychosomatics, 81(1), 5–1081. - PubMed
-
- Barkley R.A., Murphy K.R., Fischer M. (2008) ADHD in Adults: What the Science Says, New York: The Guilford Press.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical